Mandibular advancement device versus CPAP in lowering 24-hour blood pressure in patients with obstructive sleep apnoea and hypertension: the CRESCENT trial protocol
Introduction Although treatment of obstructive sleep apnoea (OSA) using continuous positive airway pressure (CPAP) reduces blood pressure (BP), adherence to CPAP is often suboptimal. A mandibular advancement device (MAD) is a guideline-endorsed alternative therapy for OSA. Still, there is limited ev...
Main Authors: | Pipin Kojodjojo, Peter Cistulli, Philip Wong, Chi-Hang Lee, Siew-Pang Chan, William Kong, Yi-Hui Ou, Juliana Tereza Colpani, Weiqiang Loke, Crystal S Cheong, Calvin W Chin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-05-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/5/e072853.full |
Similar Items
-
From CPAP to tailored therapy for obstructive sleep Apnoea
by: Kate Sutherland, et al.
Published: (2018-12-01) -
Mandibular advancement splints for the treatment of sleep apnoea syndrome
by: K Sutherland, et al.
Published: (2011-09-01) -
CPAP does not reduce 24 hour blood pressure in hypertensive obstructive sleep apnoea patients without daytime sleepiness
by: Robinson, G, et al.
Published: (2004) -
How many hours per night is enough? A systematic integrative review to identify optimal hours of CPAP therapy use for sleep apnoea
by: Hanna Chaplin, et al.
Published: (2022-12-01) -
Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
by: Turnbull, C, et al.
Published: (2019)